Advertisement
Ginkgo Bioworks Acquires Biotechnology Company Circularis For Undisclosed Terms
(RTTNews) - Ginkgo Bioworks (DNA), the leading horizontal platform for cell programming, announced Tuesday the tuck-in acquisition of Circularis, a biotechnology company with a proprietary circular RNA and promoter screening platform.
When circularized, RNA is much longer-lived in cells, improving its robustness as a potential therapeutic modality. The Circularis platform also allows ultra-high-throughput screening of promoters and other enhancers.
The Circularis platform strengthens Ginkgo's platform for development of cell and gene therapies, providing the capability to rapidly identify novel promoters with appropriate strength and tissue-specificity designed into customer specific delivery modalities.
read more
Ginkgo Bioworks Acquires Microbial Innovation Firm AgBiome's Platform Assets
Ginkgo Bioworks (DNA), which is building the leading platform for cell programming and biosecurity, announced Thursday the acquisition of microbial innovation firm AgBiome, Inc.'s platform assets, including over 115,000 fully sequenced and isolated strains, over 500 million unique gene sequences, and relevant functional data and metadata, as well as AgBiome's development pipeline.
RTTNews
|
Pred 607 dňami
Imagindairy And Ginkgo Bioworks Partner To Develop Animal-Free Non-Whey Dairy Proteins
Israeli-based foodtech company Imagindairy and Ginkgo Bioworks (DNA) announced Tuesday a new partnership with the aim to deliver a global solution for animal-free non-whey dairy protein production in a highly cost-effective manner.
RTTNews
|
Pred 623 dňami
Ginkgo Bioworks Expects To Meet FY23 Revenue Guidance Ranges
Ahead of its presentation at the 42nd Annual J.P. Morgan Healthcare Conference later on Wednesday, Ginkgo Bioworks (DNA) said it expects to meet its previously disclosed new program and revenue guidance ranges in 2023, based on its preliminary unaudited estimates.
RTTNews
|
Pred 699 dňami
Agrivalle Partners Ginkgo Bioworks To Advance Its Biological Products
Brazilian agricultural biologicals company Agrivalle announced Friday a new partnership with Ginkgo Bioworks (DNA), which is building the leading platform for cell programming and biosecurity.
RTTNews
|
Pred 732 dňami
NAMUH, Ginkgo Bioworks Ink Partnership To Develop Functional Oligosaccharides
Infant nutrition company NAMUH and Ginkgo Bioworks Holdings, Inc. (DNA) announced Wednesday a multi-product collaboration to develop functional oligosaccharides that are structurally identical to those found in human breast milk.
RTTNews
|
Pred 1056 dňami
Ginkgo Bioworks To Acquire Zymergen In All-stock Deal
Cell programming firm Ginkgo Bioworks Holdings, Inc. (DNA) and biotechnology company Zymergen, Inc. (ZY) announced Monday they have entered into a definitive agreement under which Ginkgo will acquire Zymergen in an all-stock transaction that values Zymergen at an approximately $300 million market capitalization.
RTTNews
|
Pred 1233 dňami
Lower Open Called For Hong Kong Stock Market
The Hong Kong stock market has tracked lower in consecutive trading days, slumping more than 640 points or 2.6 percent along the way. The Hang Seng Index now sits just above the 25,430-point plateau and it's likely to open to the downside again on Wednesday.
RTTNews
|
Pred 1 h 10 min
Japanese Market Modestly Higher
The Japanese stock market is trading modestly higher on Wednesday, extending the gains in the previous two sessions, following the mixed cues from Wall Street overnight. The Nikkei 225 is moving well above the 50,800 level, with gains in index heavyweights and automaker stocks. Most other sectors were mixed.
RTTNews
|
Pred 1 h 11 min
